Rochelle Bagatell

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 30

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Pediatric blood & cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sean Schoeman, Rochelle Bagatell, Anne Marie Cahill, John M Maris, Peter Mattei, Yael Mosse, Jennifer Pogoriler, Abhay Srinivasan, Michael Acord
Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single-center retrospective study. Pediatric blood & cancer 71 (4) (2024)
Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung V Huang, Matt Hall, Arlene Naranjo, Troy Richardson, Ami V Desai, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Daniel J Zheng, Haley M Newman, Stacey Zahler, Richard Aplenc, Rochelle Bagatell, Kira O Bona
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatric blood & cancer (2024)
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer (2024)
Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung V Huang, Matt Hall, Arlene Naranjo, Troy Richardson, Ami V Desai, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Daniel J Zheng, Haley M Newman, Stacey Zahler, Richard Aplenc, Rochelle Bagatell, Kira O Bona
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatric blood & cancer (2024)
Katie N Parisio, Tonia Kulp, Maureen Heil, Yimei Li, Kristen Dalton, Margaret McGrath, Cecilia Carlowicz, Meghan Donnelly, Rochelle Bagatell, Tracey Jubelirer
Yoga as a non-pharmacologic therapy to reduce dinutuximab-induced pain in patients with neuroblastoma. Pediatric blood & cancer (2024)
Sean Schoeman, Rochelle Bagatell, Anne Marie Cahill, John M Maris, Peter Mattei, Yael Mosse, Jennifer Pogoriler, Abhay Srinivasan, Michael Acord
Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single-center retrospective study. Pediatric blood & cancer 71 (4) (2024)
Sean Schoeman, Rochelle Bagatell, Anne Marie Cahill, John M Maris, Peter Mattei, Yael Mosse, Jennifer Pogoriler, Abhay Srinivasan, Michael Acord
Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single-center retrospective study. Pediatric blood & cancer (2024)
Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung V Huang, Matt Hall, Arlene Naranjo, Troy Richardson, Ami V Desai, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Daniel J Zheng, Haley M Newman, Stacey Zahler, Richard Aplenc, Rochelle Bagatell, Kira O Bona
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatric blood & cancer (2024)
Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung V Huang, Matt Hall, Arlene Naranjo, Troy Richardson, Ami V Desai, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Daniel J Zheng, Haley M Newman, Stacey Zahler, Richard Aplenc, Rochelle Bagatell, Kira O Bona
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatric blood & cancer (2024)
Andres F Espinoza, Rochelle Bagatell, Kieran McHugh, Arlene H Naranjo, Collin Van Ryn, Yesenia Rojas, Karen Lyons, R Paul Guillerman, Chaim Kirby, Penelope R Brock, Samuel Volchenboum, Thorsten Simon, Lisa States, Alexandra Miller, Barbara Krug, Sabine Sarnacki, Sabine Irtan, Hervé J Brisse, Dominique Valteau-Couanet, Dietrich von Schweinitz, Birgit Kammer, Claudio Granata, Luca Pio, Julie R Park, Jed G Nuchtern
A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study. Pediatric blood & cancer (2024)
Andres F Espinoza, Rochelle Bagatell, Kieran McHugh, Arlene H Naranjo, Collin Van Ryn, Yesenia Rojas, Karen Lyons, R Paul Guillerman, Chaim Kirby, Penelope R Brock, Samuel Volchenboum, Thorsten Simon, Lisa States, Alexandra Miller, Barbara Krug, Sabine Sarnacki, Sabine Irtan, Hervé J Brisse, Dominique Valteau-Couanet, Dietrich von Schweinitz, Birgit Kammer, Claudio Granata, Luca Pio, Julie R Park, Jed G Nuchtern
A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study. Pediatric blood & cancer (2024)
Katie N Parisio, Tonia Kulp, Maureen Heil, Yimei Li, Kristen Dalton, Margaret McGrath, Cecilia Carlowicz, Meghan Donnelly, Rochelle Bagatell, Tracey Jubelirer
Yoga as a non-pharmacologic therapy to reduce dinutuximab-induced pain in patients with neuroblastoma. Pediatric blood & cancer 71 (4) (2024)
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung V Huang, Matt Hall, Arlene Naranjo, Troy Richardson, Ami V Desai, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Daniel J Zheng, Haley M Newman, Stacey Zahler, Richard Aplenc, Rochelle Bagatell, Kira O Bona
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatric blood & cancer 71 (10) (2024)
Katie N Parisio, Tonia Kulp, Maureen Heil, Yimei Li, Kristen Dalton, Margaret McGrath, Cecilia Carlowicz, Meghan Donnelly, Rochelle Bagatell, Tracey Jubelirer
Yoga as a non-pharmacologic therapy to reduce dinutuximab-induced pain in patients with neuroblastoma. Pediatric blood & cancer 71 (4) (2024)
Andres F Espinoza, Rochelle Bagatell, Kieran McHugh, Arlene H Naranjo, Collin Van Ryn, Yesenia Rojas, Karen Lyons, R Paul Guillerman, Chaim Kirby, Penelope R Brock, Samuel Volchenboum, Thorsten Simon, Lisa States, Alexandra Miller, Barbara Krug, Sabine Sarnacki, Sabine Irtan, Hervé J Brisse, Dominique Valteau-Couanet, Dietrich von Schweinitz, Birgit Kammer, Claudio Granata, Luca Pio, Julie R Park, Jed G Nuchtern
A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study. Pediatric blood & cancer 71 (10) (2024)
Andres F Espinoza, Rochelle Bagatell, Kieran McHugh, Arlene H Naranjo, Collin Van Ryn, Yesenia Rojas, Karen Lyons, R Paul Guillerman, Chaim Kirby, Penelope R Brock, Samuel Volchenboum, Thorsten Simon, Lisa States, Alexandra Miller, Barbara Krug, Sabine Sarnacki, Sabine Irtan, Hervé J Brisse, Dominique Valteau-Couanet, Dietrich von Schweinitz, Birgit Kammer, Claudio Granata, Luca Pio, Julie R Park, Jed G Nuchtern
A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study. Pediatric blood & cancer 71 (10) (2024)
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung V Huang, Matt Hall, Arlene Naranjo, Troy Richardson, Ami V Desai, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Daniel J Zheng, Haley M Newman, Stacey Zahler, Richard Aplenc, Rochelle Bagatell, Kira O Bona
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatric blood & cancer 71 (10) (2024)
Puja J Umaretiya, Arlene Naranjo, Fan F Zhang, Meredith S Irwin, Steven G DuBois, Rochelle Bagatell, Kira O Bona
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jamie Shoag, Yimei Li, Kelly D Getz, Yuan-Shung V Huang, Matt Hall, Arlene Naranjo, Troy Richardson, Ami V Desai, Puja J Umaretiya, Rahela Aziz-Bose, Colleen A Kelly, Daniel J Zheng, Haley M Newman, Stacey Zahler, Richard Aplenc, Rochelle Bagatell, Kira O Bona
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatric blood & cancer (2024)
Rochelle Bagatell, Steven G DuBois, Arlene Naranjo, Jen Belle, Kelly C Goldsmith, Julie R Park, Meredith S Irwin, null null
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma. Pediatric blood & cancer (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Navin R Pinto, Arlene Naranjo, Xiangming Ding, Fan F Zhang, Emily Hibbitts, Rebekah Kennedy, Rachelle Tibbetts, Shannon Wong-Michalak, David W Craig, Zarko Manojlovic, Michael D Hogarty, Susan Kreissman, Rochelle Bagatell, Meredith S Irwin, Julie R Park, Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ami Vijay Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak, Arlene Naranjo, Wendy B London, Sheena C Tenney, Mitchell B Diccianni, Jacquelyn A Hank, Marguerite T Parisi, Barry L Shulkin, Malcolm A Smith, Jeffrey A Moscow, Hiroyuki Shimada, Katherine K Matthay, Susan L Cohn, John M Maris, Rochelle Bagatell, Paul M Sondel, Julie R Park, Alice Lin-Tsing Yu
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Benjamin J Lerman, Yimei Li, Cecilia Carlowicz, Meaghan P Granger, Thomas Cash, Arhanti Sadanand, Katherine M Somers, Aeesha Ranavaya, Brian D Weiss, Michelle Choe, Jennifer H Foster, Navin R Pinto, Daniel A Morgenstern, Margarida Simão Rafael, Keri A Streby, Rachel N Zeno, Rajen J Mody, Sahr Yazdani, Ami Vijay Desai, Margaret E Macy, Suzanne Shusterman, Sara M Federico, Rochelle Bagatell
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, Susan L Cohn, Wendy B London, Julie M Gastier-Foster, Nilsa C Ramirez, Ruthann Pfau, Shalini Reshmi, Elizabeth Wagner, Jed Nuchtern, Shahab Asgharzadeh, Hiroyuki Shimada, John M Maris, Rochelle Bagatell, Julie R Park, Michael D Hogarty
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Steven G DuBois, Rochelle Bagatell
Improving Outcomes in Children With High-Risk Neuroblastoma: The Role of Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Alice Lin-Tsing Yu, Andrew L Gilman, M Fevzi Ozkaynak, Arlene Naranjo, Mitchell B Diccianni, Jacek Gan, Jacquelyn A Hank, Ayse Batova, Wendy B London, Sheena C Tenney, Malcolm A Smith, Barry L Shulkin, Marguerite Parisi, Katherine K Matthay, Susan L Cohn, John M Maris, Rochelle Bagatell, Julie R Park, Paul M Sondel
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)